ArticleBlood advances2019

CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy.

Vinodh Pillai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.